OTC/SmallCap IRW

The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare

Partnership will bring first GMP manufactured products to be sold through Valens in bothAustralia and New Zealand Access to Epsilon's GMP facility in Australia to provide Valens with future access to global markets includingLatin America, Europe, UK and Asia-Pacific KELOWNA, BC, Sept. 8, 2021 ...

2021-09-08 19:00 4375

Luxventure Entered into Agreement with Hainan Supply and Marketing Daji Digital Technology Industry Co., Ltd., the cross-border E-commerce subsidiary of Hainan Airline

SHISHI, China, Sept. 7, 2021 /PRNewswire/ -- KBS Fashion Group Limited ("KBS" or the "Company") (NASDAQ: KBSF

2021-09-08 03:39 9911

IINX's subsidiary applied for a patent on high rate rapid charge-discharge aluminum ion battery to China Intellectual Property Administration and has been accepted

LAS VEGAS, Sept. 7, 2021 /PRNewswire/ -- Ionix Technology, Inc. (OTCQB: IINX), ("Ionix Technology", "IINX" or "the Company"), today announced that one of Ionix's wholly-owned subsidiaries, Huixiang Energy Technology (Suzhou) Co., Ltd (Huixiang Energy), has submitted a patent application for its s...

2021-09-07 21:15 7630

Sasol and Central Energy Fund sign strategic MOU to accelerate gas development in South Africa

JOHANNESBURG, Sept. 7, 2021 /PRNewswire/ -- Sasol and the Central Energy Fund (CEF) have signed a memorandum of understanding (MOU) to collaborate on accelerating the development of gas solutions inSouth Africa. This agreement brings togetherSouth Africa's two leading pioneers of the gas industry...

2021-09-07 20:58 6797

Recon Announces RMB9 Million Contract for Disposal of Oil Sludge from Yumen Oilfield

BEIJING, Sept. 7, 2021 /PRNewswire/ -- Recon Technology Limited (NASDAQ: RCON) ("Recon" or the "Company") today announced that its subsidiary, Gansu BHD Environmental Technology Co., Ltd ("Gansu BHD"), and Yumen Oilfield Engineering Construction Co., a wholly-owned subsidiary of China National Pe...

2021-09-07 20:30 6528

Tantech Subsidiary Completes Another Major New Order for 50 Midibuses

LISHUI, China, Sept. 7, 2021 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company"), a clean energy company inChina, today announced that its subsidiary, Shangchi Automobile Co., Ltd., has fulfilled another major new order for 50 midibuses, with delivery for use inEgypt....

2021-09-07 20:00 7461

Further Study in humans shows that the DTH response, the basis for CoviDTH, is highly durable and persists for at least one year after COVID-19 exposure or vaccine administration

VANCOUVER, BC and SAN CRISTÓBAL DE LA LAGUNA, Spain, Sept. 7, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "the Company") is pleased to announce that the Scientific Advisor for its CoviDTH program,Yvelise Barrios, MD, PhD, and Clinical Immuno...

2021-09-07 20:00 7200

WeTrade Announces Partnership with Ticket Agents of Universal Studio Beijing

BEIJING, Sept. 7, 2021 /PRNewswire/ -- WeTrade Group Inc. ("Wetrade" or the "Company") (US: WETG), which is believed as the world's first technical service provider of SAAS and Cloud Intelligent System for micro businesses, today announced that it has signed partnership agreement with a number of...

2021-09-07 19:00 4287

Ethics Approval Granted for Clinical Trial of World's First Nasal Swab Designed Specifically for Children

* Rhinomed has created the world's first nasal swab designed specifically for children — The Rhinoswab Junior™ * Ethics approval has been received for a clinical trial to commence with the Murdoch Children's Research Institute (MCRI) at The Royal Children's Hospital in Melbourne * Trial seek...

2021-09-07 18:00 3020

NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease

-- Using NeuExcell's neuroregenerative gene therapy platform, the collaboration aims to develop an effective and safe treatment for patients suffering from Huntington's Disease. -- Spark Therapeutics' excellence in R&D and proprietary adeno-associated virus (AAV) vector gene therapy platform ma...

2021-09-07 12:00 4521

Fosun International Officially Selected as a Constituent Stock of Hang Seng ESG 50 Index

HONG KONG, Sept. 6, 2021 /PRNewswire/ -- Fosun International officially was selected as a constituent stock of Hang Seng ESG 50 Index (top 50 large-to-mid cap). Hang Seng ESG 50 Index aims at capturing the overall performance of Top 50 ESG leaders with relatively high market capitalization listed...

2021-09-06 16:51 8088
1 ... 8182838485